Surprisingly, silencing endogenous TGFB1 in PDAC and TNBC-derived cancer cells with known autocrine TGFβ1 production allowed exogenous TGFβ1 to elicit a more pronounced migratory and growth-inhibitory response. Here, TGFB1 is linked to cancer.